According to Kuros Biosciences's latest financial reports the company's current EPS (TTM) is -HK$881.19. In 2023 the company made an earnings per share (EPS) of -HK$3.52 an increase over its 2022 EPS that were of -HK$3.62.
Year | EPS | Change |
---|---|---|
2023 | -HK$3.52 | -2.9% |
2022 | -HK$3.62 | 84.91% |
2021 | -HK$1.96 | -52.78% |
2020 | -HK$4.15 | -21.05% |
2019 | -HK$5.26 | -41.8% |
2018 | -HK$9.03 | -39.7% |
2017 | -HK$14.98 | -38.55% |
2016 | -HK$24.38 | -98.64% |
2015 | -HK$1,789 | 134.29% |
2014 | -HK$763.37 | -18.41% |
2013 | -HK$935.62 | 138.21% |
2012 | -HK$392.77 | -83.54% |
2011 | -HK$2,386 | 1166.55% |
2010 | -HK$188.42 | -93.42% |
2009 | -HK$2,864 | -3.85% |
2008 | -HK$2,979 | 309.32% |
2007 | -HK$727.73 | -79.05% |
2006 | -HK$3,473 | 27.06% |
2005 | -HK$2,734 | -8.02% |
2004 | -HK$2,972 |